Sarah Moody

Sarah Moody

Auto-generated profile, based on publicly available information

Sarah Moody

Wellcome Sanger Institute

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2025 in Nature
Verified
Journal Article
Open access
PDF file
MDMarcos Díaz-Gay
Marcos Díaz-Gay
WSWellington dos Santos
Wellington dos Santos
SMSarah Moody
Sarah Moody
MKMariya Kazachkova
Mariya Kazachkova
AAAmmal Abbasi
Ammal Abbasi
LALudmil B. Alexandrov
Ludmil B. Alexandrov
Incidence rates of colorectal cancer vary geographically and have changed over time1. Notably, in the past two decades, the incidence of early-onset colorectal cancer, which affects individuals below 50 years of age, has doubled in many countries2–5. The reasons for this increase are unknown. Here we investigate whether mutational processes contribute to geographic and age-related differences by examining 981 colorectal cancer genomes from 11 countries. No major differences were found in microsatellite-unstable cancers, but variations in mutation burden and signatures were observed in the 802 microsatellite-stable cases. Multiple signatures, most with unknown aetiologies, exhibited varying prevalence in Argentina, Brazil, Colombia, Russia and Thailand, indicating geographically diverse levels of mutagenic exposure. Signatures SBS88 and ID18, caused by the bacteria-produced mutagen colibactin6,7, had higher mutation loads in countries with higher colorectal cancer incidence rates. SBS88 and ID18 were also enriched in early-onset colorectal cancers, being 3.3 times more common in individuals who were diagnosed before 40 years of age than in those over 70 years of age, and were imprinted early during colorectal cancer development. Colibactin exposure was further linked to APC driver mutations, with ID18 being responsible for about 25% of APC driver indels in colibactin-positive cases. This study reveals geographic and age-related variations in colorectal cancer mutational processes, and suggests that mutagenic exposure to colibactin-producing bacteria in early life may contribute to the increasing incidence of early-onset colorectal cancer.

18 October 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SMSarah Moody
Sarah Moody
SSSergey Senkin
Sergey Senkin
SIS. M. Ashiqul Islam
S. M. Ashiqul Islam
JWJingwei Wang
Jingwei Wang
DNDariush Nasrollahzadeh
Dariush Nasrollahzadeh
MSMichael R. Stratton
Michael R. Stratton

1 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
SSSergey Senkin
Sergey Senkin
SMSarah Moody
Sarah Moody
MDMarcos Díaz-Gay
Marcos Díaz-Gay
BABehnoush Abedi-Ardekani
Behnoush Abedi-Ardekani
TCThomas Cattiaux
Thomas Cattiaux
PBPaul Brennan
Paul Brennan
International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden1. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence2. Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations. Here we sequenced 962 clear cell renal cell carcinomas from 11 countries with varying incidence. The somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures characteristic of aristolochic acid compounds were present in most cases, but these were rare elsewhere. In Japan, a mutational signature of unknown cause was found in more than 70% of cases but in less than 2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher incidence rates of kidney cancer. Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension, suggesting that non-mutagenic mechanisms of action underlie these risk factors. The results of this study indicate the existence of multiple, geographically variable, mutagenic exposures that potentially affect tens of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.

1 July 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
EMEmily Mitchell
Emily Mitchell
MPMy H. Pham
My H. Pham
ACAnna Clay
Anna Clay
RSRashesh Sanghvi
Rashesh Sanghvi
NWNicholas Williams
Nicholas Williams
MSMichael R. Stratton
Michael R. Stratton
Several chemotherapeutic agents act by increasing DNA damage in cancer cells, triggering cell death. However, there is limited understanding of the extent and long-term consequences of collateral DNA damage in normal tissues. To investigate the impact of chemotherapy on mutation burdens and the cell population structure of normal tissue, we sequenced blood cell genomes from 23 individuals aged 3–80 years who were treated with a range of chemotherapy regimens. Substantial additional somatic mutation loads with characteristic mutational signatures were imposed by some chemotherapeutic agents, but the effects were dependent on the drug and blood cell types. Chemotherapy induced premature changes in the cell population structure of normal blood, similar to those caused by normal aging. The results show the long-term biological consequences of cytotoxic agents to which a substantial fraction of the population is exposed as part of disease management, raising mechanistic questions and highlighting opportunities for the mitigation of adverse effects.

13 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SIS M Ashiqul Islam
S M Ashiqul Islam
MDMarcos Díaz-Gay
Marcos Díaz-Gay
YWYang Wu
Yang Wu
MBMark Barnes
Mark Barnes
RVRaviteja Vangara
Raviteja Vangara
LALudmil B Alexandrov
Ludmil B Alexandrov
SUMMARY: Mutational signature analysis is commonly performed in genomic studies surveying cancer and normal somatic tissues. Here we present SigProfilerExtractor, an automated tool for accurate de novo extraction of mutational signatures for all types of somatic mutations. Benchmarking with a total of 34 distinct scenarios encompassing 2,500 simulated signatures operative in more than 60,000 unique synthetic genomes and 20,000 synthetic exomes demonstrates that SigProfilerExtractor outperforms thirteen other tools across all datasets with and without noise. For genome simulations with 5% noise, reflecting high-quality genomic datasets, SigProfilerExtractor outperforms other approaches by elucidating between 20% and 50% more true positive signatures while yielding more than 5-fold less false positive signatures. Applying SigProfilerExtractor to 4,643 whole-genome sequenced and 19,184 whole-exome sequenced cancers reveals four previously missed mutational signatures. Two of the signatures are confirmed in independent cohorts with one of these signatures associating with tobacco smoking. In summary, this report provides a reference tool for analysis of mutational signatures, a comprehensive benchmarking of bioinformatics tools for extracting mutational signatures, and several novel mutational signatures including a signature putatively attributed to direct tobacco smoking mutagenesis in bladder cancer and in normal bladder epithelium.

31 March 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LTLaura Torrens
Laura Torrens
SMSarah Moody
Sarah Moody
ACAna Carolina de Carvalho
Ana Carolina de Carvalho
MKMariya Kazachkova
Mariya Kazachkova
BABehnoush Abedi-Ardekani
Behnoush Abedi-Ardekani
SPSandra Perdomo
Sandra Perdomo
Tobacco smoke, alone or combined with alcohol, is the predominant cause of head and neck cancer (HNC). We explore how tobacco exposure contributes to cancer development by mutational signature analysis of 265 whole-genome sequenced HNC samples from eight countries. Six tobacco-associated mutational signatures were detected, including some not previously reported. Differences in HNC incidence between countries corresponded with differences in mutation burdens of tobacco-associated signatures, consistent with the dominant role of tobacco in HNC causation. Differences were found in the burden of tobacco-associated signatures between anatomical subsites, suggesting that tissue-specific factors modulate mutagenesis. We identified an association between tobacco smoking and alcohol-related signatures, indicating a combined effect of these exposures. Tobacco smoking was associated with differences in the mutational spectra, repertoire of driver mutations in cancer genes and patterns of copy number change. Our results demonstrate the multiple pathways by which tobacco smoke can influence the evolution of cancer cell clones.